Julie Rubinstein, President at Adaptive Biotechnologies Corp (ADPT), sold 15,000 shares at $56.23 ($843K) on 2021-02-26, disclosed to the SEC on 2021-03-01.
Open-market sale of $843k ADPT by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ADPT | SELL | 2026-10-05 | $1.0M | — | Filing → |
| ADPT | SELL | 2026-04-29 | $271K | — | Filing → |
| ADPT | SELL | 2026-04-24 | $798K | — | Filing → |